Patients' attitudes to the use of placebos: Results from a New Zealand survey

New Zealand Medical Journal

Volumn 122, Issue 1296, 2009, Pages 35-46

  Chen, Guo Feng ^a   Johnson, Malcolm H ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; HEALTH SURVEY; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; PATIENT ATTITUDE; PATIENT CARE; PATIENT DECISION MAKING; PATIENT SAFETY; RESEARCH SUBJECT; SELF REPORT;

ADULT; AGE FACTORS; AGED; CONTROLLED CLINICAL TRIALS AS TOPIC; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; PATIENT PARTICIPATION; PLACEBO EFFECT; QUESTIONNAIRES; SOCIOECONOMIC FACTORS; THERAPEUTIC HUMAN EXPERIMENTATION;

EID: 67649946690     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Thomson RJ, Buchanan WJ. Placebos and general practice: attitudes to, and the use of, the placebo effect. NZ Med J. 1982;95:492-94.
2. Shapiro AK, Struening EL. The use of placebos: a study of ethics and physicians' attitudes. Int J Psychiatry in Med. 1973;4: 17-29.
3. Lynoe N, Mattsson B, Sandlund M. The attitudes of patients and physicians towards placebo treatment - a comparative study. Soc Sci Med. 1993;36:767-74.
4. Hróbjartsson A, Norup M. The use of placebo interventions in medical practice - a national questionnaire survey of Danish clinicians. Eval Health Prof. 2003;26:153-65.
5. Nitzan U, Litchenberg P. Questionnaire survey on the use of placebo. Br Med J 2004;329: 944-46.
6. Tilburt JC, Emanuel EJ, Kaptchuk TJ, et al. Prescribing "placebo treatments": results of national survey of US internists and rheumatologists. Br Med J. 2008;337: a1938.
7. Rawlinson MC. Truth-telling and paternalism in the clinic: philosophical reflections on the use of placebos in medical practice. In White L, Tursky B, Schwartz GE, eds, Placebo, Theory, Research, and Mechanism. New York: Guilford Press, 1985:403-418.
8. Berthelot JM, Maugars Y, Abgrall M, Prost A. Interindividual variations in beliefs about the placebo effect: a study in 300 rheumatology inpatients and 100 nurses. Joint, Bone, Spine. 2001; 68:65-70.
9. Spiro HM. Doctors, Patients and Placebos. London: Yale University Press. 1986.
10. Hill J. Placebos in clinical care: for whose pleasure? Lancet. 2003;362:254.
11. Petrovic P, Kalso, E, Petersson, KM, Ingvar, M. Placebo and opioid analgesia: Imaging a shared neuronal network. Science. 2002;295:1737-40.
12. Price DD. Endogenous opioid and non-opioid pathways as mediators of placebo analegsia. In Guess HA, Kleinman A, Kusek JW, Engel LW, eds. The Science of the Placebo: toward an interdisciplinary research agenda. London: BMJ Books; 2002:183-206.
13. Benedetti F, Pollo A, Lopiano L, et al. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/ nocebo responses. J Neurosci. 2003;23:4315-23.
14. de la Fuente-Fernandez R, Ruth TJ, Sossi V, et al. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science. 2001; 293:1164-66
15. Hoffman GA, Harrington A, Fields H L. Pain and the Placebo: what we have learned. Perspect Biol Med. 2005;48:248-65
16. Pollo A, Torre E, Lopiano L, et al. Expectation modulates the response to subthalamic nucleus stimulation in Parkinsonian patients. NeuroReport, 2002;13:1383-86.
17. Benedetti F, Colloca L, Torre E, et al. Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus. Nat Neurosci. 2004;7:587-88.
18. Benedetti B, Mayberg HS, Wager TD, et al. Neurobiological Mechanisms of the Placebo Effect. J Neurosci. 2005;25:10390-402.
19. Kirsch I, Moore TJ, Scoboria A, Nicholls SS. The emperor's new drugs: An analysis of antidepressant medication data submitted to the U.S. Food and Drug Administration. Prev Treat. 2002;5:1-12.
20. Walsh BT, Seidman SN, Sysko R, Gould M. Placebo response in studies of major depression: Variable, substantial, and growing. JAMA. 2002; 287:1840-47.
21. Khan A, Detke M, Khan SR, Mallinckrodt C. Placebo response and antidepressant clinical trial outcome. J Nerv Ment Dis. 2003;191:211-18.
22. Di Blasi Z, Harkness E, Ernst E, et al. Influence of context effects on health outcomes: A systematic review. Lancet. 2001;357:757-62.
23. Guess HL, Kleinman A, Kusek JW, Engel LW. The science of the placebo: Toward an interdisciplinary research agenda. 2002 London: BMJ Books.
24. Colloca L, Lopiano L, Lanotte M, Benedetti F. Overt versus covert treatment for pain, anxiety, and Parkinson's disease. Lancet Neurol. 2004;3:679-84.
25. Delbanco TA. piece of my mind. Leeches, spiders, and astrology: predilections and predictions JAMA. 1998;280:1560-62.
26. Greene P J, Wayne P M, Kerr C E, et al. The powerful placebo: doubting the doubters. Adv in Mind-Body Med. 2001;17:298-307.
27. Koshi EV, Short AC. Placebo theory and its implications for research and clinical practice: A review of the recent literature. Pain Prac. 2007;7:4-20.
28. Linde K, Dincer F. How informed is consent in sham-controlled trials of acupuncture? J Altern Complem Med 2004;10:379-85.
29. Final Report of the National Placebo Working Committee on the Appropriate Use of Placebos in Clinical Trials in Canada (July 2004). Canada [cited 2009 Apr 27]. Available from http://www.cihr-irsc.gc.ca/e/ 25139.html
30. McQuay HJ. Moore RA. Placebo. Postgrad Med J. 2005;81:155-60.
31. Birch, S. A Review and analysis of placebo treatments, placebo effects, and placebo controls in trials of medical procedures when sham is not inert. J Altern Complem Med. 2006;12:303-10.
32. Asai A, Ohnishi M, Nishigaki E, et al. Focus group interviews examining attitudes toward medical research among the Japanese: a qualitative study. Bioethics. 2004;18:448-70.
33. Tom Xu, K, Borders, T F. Gender, Health, and Physician Visits Among Adults in the United States. Am J Public Health. 2003;93:1076-79.
34. Murasko, JE. Gender differences in the management of risk factors for cardiovascular disease: The importance of insurance status. Soc Sci Med. 2006;63:1745-56.
35. Statistics New Zealand. QuickStats about Education and Training. Wellington (NZ) [cited 2009 Apr 27]. Available from: http:// www.stats.govt.nz/census/2006-census-data/ quickstats-about-education-and-training/ quickstats-about-education-and-training.htm?page=para003Master
36. Bok S. Lying: moral choice in public and private life. New York: Pantheon, 1978.
37. Hummer M, Holzmeister R, Kemmler G, et al. Attitudes of patients with schizophrenia toward placebo-controlled clinical trials. J Clin Psychiat. 2003;64:277-81.
38. Cassileth BR, Lusk EJ, Miller DS, Hurwitz S. Attitudes toward clinical trials among patients and the public. JAMA. 1982;248: 968-70.
39. De Deyn PP, D'Hooge R. Placebos in clinical practice and research. J Med Ethics. 1996; 22: 140-46.